GLP-1 and GIP agonism has no direct actions in human hepatocytes or hepatic stellate cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
GLP-1 and GIP agonism has no direct actions in human hepatocytes or hepatic stellate cells ; volume:81 ; number:1 ; day:28 ; month:11 ; year:2024 ; pages:1-16 ; date:12.2024
Cellular and molecular life sciences ; 81, Heft 1 (28.11.2024), 1-16, 12.2024
- Creator
-
Silva Lima, Natália da
Cabaleiro, Alba
Novoa, Eva
Riobello, Cristina
Knerr, Patrick J.
He, Yantao
Esquinas-Román, Eva M.
González-García, Ismael
Prevot, Vincent
Schwaninger, Markus
Dieguez, Carlos
López, Miguel
Müller, Timo D.
Varela-Rey, Marta
Douros, Jonathan D.
Nogueiras, Ruben
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00018-024-05507-6
- URN
-
urn:nbn:de:101:1-2502132217090.829662586170
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Silva Lima, Natália da
- Cabaleiro, Alba
- Novoa, Eva
- Riobello, Cristina
- Knerr, Patrick J.
- He, Yantao
- Esquinas-Román, Eva M.
- González-García, Ismael
- Prevot, Vincent
- Schwaninger, Markus
- Dieguez, Carlos
- López, Miguel
- Müller, Timo D.
- Varela-Rey, Marta
- Douros, Jonathan D.
- Nogueiras, Ruben
- SpringerLink (Online service)
Other Objects (12)
Interaktion der GLP-1- und GIP-Rezeptoren
Tirzepatid: GIP-/GLP-1-Rezeptoragonist zur Therapie des Typ-2-Diabetes – SURPASS-Studienprogramm
Tirzepatid: GIP-/GLP-1-Rezeptoragonist zur Therapie des Typ-2-Diabetes – SURPASS-Studienprogramm
Inflammatorische Regulation der Inkretinhormone GLP-1 und GIP und deren Relevanz für den Glukosemetabolismus
Extracellular vesicles from steatotic hepatocytes provoke pro-fibrotic responses in cultured stellate cells
Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis
Dual GLP-1/GIP Agonist Tirzepatide for Diabetes and Obesity: A Review of the Evidence
Leitung GIP
Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells
Generation of proliferating hepatocytes, liver sinusoidal endothelial cells and stellate cells and establishment of a genotoxicity assay based on proliferating hepatocytes
Generation of proliferating hepatocytes, liver sinusoidal endothelial cells and stellate cells and establishment of a genotoxicity assay based on proliferating hepatocytes
GIP und GLP-1-Rezeptoragonismus in der Therapie des Typ 2 Diabetes mit Fokus auf Tirzepatid
Interaktion der GLP-1- und GIP-Rezeptoren
Tirzepatid: GIP-/GLP-1-Rezeptoragonist zur Therapie des Typ-2-Diabetes – SURPASS-Studienprogramm
Tirzepatid: GIP-/GLP-1-Rezeptoragonist zur Therapie des Typ-2-Diabetes – SURPASS-Studienprogramm
Inflammatorische Regulation der Inkretinhormone GLP-1 und GIP und deren Relevanz für den Glukosemetabolismus
Extracellular vesicles from steatotic hepatocytes provoke pro-fibrotic responses in cultured stellate cells
Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis
Dual GLP-1/GIP Agonist Tirzepatide for Diabetes and Obesity: A Review of the Evidence
Leitung GIP
Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells
Generation of proliferating hepatocytes, liver sinusoidal endothelial cells and stellate cells and establishment of a genotoxicity assay based on proliferating hepatocytes
Generation of proliferating hepatocytes, liver sinusoidal endothelial cells and stellate cells and establishment of a genotoxicity assay based on proliferating hepatocytes
GIP und GLP-1-Rezeptoragonismus in der Therapie des Typ 2 Diabetes mit Fokus auf Tirzepatid
Interaktion der GLP-1- und GIP-Rezeptoren
Tirzepatid: GIP-/GLP-1-Rezeptoragonist zur Therapie des Typ-2-Diabetes – SURPASS-Studienprogramm
Tirzepatid: GIP-/GLP-1-Rezeptoragonist zur Therapie des Typ-2-Diabetes – SURPASS-Studienprogramm
Inflammatorische Regulation der Inkretinhormone GLP-1 und GIP und deren Relevanz für den Glukosemetabolismus
Extracellular vesicles from steatotic hepatocytes provoke pro-fibrotic responses in cultured stellate cells
Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis
Dual GLP-1/GIP Agonist Tirzepatide for Diabetes and Obesity: A Review of the Evidence
Leitung GIP
Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells
Generation of proliferating hepatocytes, liver sinusoidal endothelial cells and stellate cells and establishment of a genotoxicity assay based on proliferating hepatocytes
Generation of proliferating hepatocytes, liver sinusoidal endothelial cells and stellate cells and establishment of a genotoxicity assay based on proliferating hepatocytes